Skip to main content

Table 2 Zone of inhibition (mm) for the synthesized triphenylamine chalcones and standard controls against test microbes

From: Design, synthesis, docking studies and antibiotic evaluation (in vitro) of some novel (E)-4-(3-(diphenylamino)phenyl)-1-(4-methoxyphenyl)-2-methylbut-3-en-1-one and their analogues

Test organisms Triphenylamine chalcones
1a 1b 1c 1d 2a 2b 2c 2d Cip Flu
E. coli 14 16 15 20 13 18 19 16 30
P. aeruginosa 15 18 18 18 16 18 20 19 40
S. typhi 16 14 17 16 16 13 15 18 26
S. aureus 13 15 14 18 13 13 15 15 28
B. subtilis 16 17 20 17 18 20 20 18 25
MRSA 14 16 19 15 16 17 16 19 30
C. albicans 17 13 20 13 16 20 20 18 20
A. niger 25 30 23 20 20 22 21 23 22
  1. Key; (–): Not determined, Cip ciprofloxacin, Flu fluconazole